ArticleScientific reports2025
Elevated effluent lactate independently predicts the adverse outcomes of peritoneal dialysis associated peritonitis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global, Regional, and Country Incidence of Peritoneal Dialysis-Associated Peritonitis in the Contemporary Peritoneal Dialysis Practice: A Systematic Review and Meta-Analysis.Medical sciences (Basel, Switzerland) · 2026Pooled it
- Prediction of Imminent Peritoneal Dialysis-Associated Peritonitis Using Time-Updated Electronic Health Records and Machine Learning: A Temporal Validation Study.Journal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Peritonitis is the primary complication associated with peritoneal dialysis (PD). The acute inflammatory response is promoted by glycolysis, thereby enhancing lactate production. Lactate level has been identified as a prognostic factor of many acute inflammatory disease, however with no observation in peritoneal dialysis associated peritonitis (PDAP). Therefore, the need to monitor lactate levels of PDAP patients should be emphasized. Retrospective data on effluent and serum lactate levels and other clinical and laboratory characteristics for PDAP (2022-Nov to 2024-Jul) were analyzed. No-cure was defined as adverse outcomes like recurrence, relapse, catheter removal, hemodialysis transfer ≥ 30 days or death. We used logistic regressions and receiver operating characteristic curve (ROC) analysis to assess factors linked to outcomes and the lactate level predictive accuracy for PDAP adverse outcomes, respectively. The total number of PDAP episodes enrolled was 118, involving 100 PD patients. Regarding the clinical outcomes of the PDAP, 84 episodes were cured, while 34 episodes were no-cure. Catheter removal and transfer to hemodialysis were the leading adverse outcomes (n = 22, 64.7%), followed by relapse and recurrence. Compared with the cure group, no-cure group showed significantly lower serum albumin levels, higher effluent white cell count (WCC) on day 5, and higher percentage of gram-negative bacteria infections. The effluent lactate levels in no-cure group were statistically higher than those of cure group (8.50 [5.48, 13.1] versus 5.4 [3.18, 8.25] mmol/L, p < 0.001). Patients with higher effluent lactate levels (odds ratio [OR] = 1.419, p < 0.001) and gram-negative peritonitis (OR = 6.444, p = 0.009) had a higher risk of adverse outcomes. A moderate discriminative capacity for adverse outcomes was observed in the effluent lactate levels through ROC analyses (area under curve [AUC] = 0.752, p < 0.001), and with a threshold values of 10.2 mmol/L yielding the highest Youden's index. Elevated levels of lactate in the effluent may independently indicate adverse outcomes in PDAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.